about
Liver bioengineering: current status and future perspectivesThe role of interferon-γ inducible protein-10 in a mouse model of acute liver injury post induced pluripotent stem cells transplantationA review on the therapeutic potential of embryonic and induced pluripotent stem cells in hepatic repair.VEGF(165) expressing bone marrow mesenchymal stem cells differentiate into hepatocytes under HGF and EGF induction in vitro.Stages based molecular mechanisms for generating cholangiocytes from liver stem/progenitor cells.Human adipose tissue derived stem cells promote liver regeneration in a rat model of toxic injuryHypoxia preconditioned bone marrow mesenchymal stem cells promote liver regeneration in a rat massive hepatectomy model.Unbalanced distribution of materials: the art of giving rise to hepatocytes from liver stem/progenitor cells.Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet?Cell therapies for liver diseases.Cells and materials for liver tissue engineering.Model systems and clinical applications of hepatic stem cells for liver regeneration.Novel management of acute or secondary biliary liver conditions using hepatically differentiated human dental pulp cells.Rodent animal models for surrogate analysis of cell therapy in acute liver failureBone mesenchymal stem cell transplantation via four routes for the treatment of acute liver failure in rats.Functional ion channels in mouse cardiac c-kit(+) cells.Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.Inhibition of the RhoGTPase Cdc42 by ML141 enhances hepatocyte differentiation from human adipose-derived mesenchymal stem cells via the Wnt5a/PI3K/miR-122 pathway: impact of the age of the donor.
P2860
Q34322889-9D758D53-D905-459A-9EF8-ADC0572570F3Q34507030-F69A650E-B78B-40C4-938A-BE293509FA9AQ35746393-4D235545-9E74-42EB-ABE2-471D0304BF06Q36369215-F4560BFA-91D6-4905-B64B-1D1BA3697F1EQ37285257-BF26926D-B6FD-4D12-B294-8A56B95C1779Q37339242-F54417BF-DE73-4A33-BA58-BD8E7671F3D0Q37372327-7AA86367-964A-45F6-BAE8-869DC5309479Q37562312-1B310CE7-FEB3-4266-9695-D0C187418115Q37885457-0C8695F3-D1F3-49B7-A240-8E5AFDCB8537Q37964633-114A2643-31DE-4B32-8B1F-4681DCCC0F3FQ38057877-C37DBB22-345E-40BE-9049-FD33D8605E79Q38552153-6A0A6706-0D89-4F87-A916-F9082A4896ECQ42107098-A08BBCBB-6A99-437F-84E2-AA910D1F0BF5Q42556938-811E0DBF-ABA8-4770-8124-2E0AA2B07E26Q42857033-0888B248-170B-498A-8253-58EB22A2F6F7Q43174614-DE79B26C-04ED-4403-A6DB-1E364FDED4D6Q53155879-ACEED9F4-2401-4718-B6C6-BBDFBB578F31Q55489971-C387A66E-C58E-4DC3-80BA-4B96691E23B7
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The use of stem cells in liver disease.
@ast
The use of stem cells in liver disease.
@en
type
label
The use of stem cells in liver disease.
@ast
The use of stem cells in liver disease.
@en
prefLabel
The use of stem cells in liver disease.
@ast
The use of stem cells in liver disease.
@en
P1476
The use of stem cells in liver disease.
@en
P2093
Kenneth L Brayman
Tanya R Flohr
P356
10.1097/MOT.0B013E328320FD7B
P577
2009-02-01T00:00:00Z